Natalia Valdiviezo

7PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMidwifery not elsewhere classifiedMolecular targetsForensic epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 09, 2026
Osimertinib After Definitive Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC: Subsequent Treatments and PPO From the Phase III LAURA Study.

|Jan 12, 2026
Giant Primary Hepatic Endodermal Sinus Tumor: Multidisciplinary Management and Long-Term Survival.

Katia Roque, Rossana Ruiz, Renier Cruz

|Nov 24, 2025
Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple-Negative Breast Cancer.

Zaida Morante, Yomali Ferreyra, Iris Otoya

|Jul 04, 2024
Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2-Positive Breast Cancer.

Iris Otoya, Natalia Valdiviezo, Zaida Morante

|Dec 02, 2023
CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer.

Pasi A Jänne, David Planchard, Kunihiko Kobayashi

|Nov 12, 2022
Real-world outcomes of anti-EGFR therapy in advanced non-small cell lung cancer EGFR mutated in Peru.

Marco Galvez-Nino, Rossana Ruiz, Katia Roque

Pageof 2

Frequent Collaborators

3 joint publications

Marco Galvez-Nino

3 joint publications

Rossana Ruiz

3 joint publications

Mivael Olivera Hurtado de Mendoza

3 joint publications

Carlos Castañeda